Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status

BACKGROUND: Patients with human immunodeficiency virus (HIV) and/or chronic hepatitis C virus (HCV) infection may be prescribed statins as treatment for metabolic/cardiovascular disease, but it remains unclear if the risk of acute liver injury (ALI) is increased for statin initiators compared to non...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Infect Dis
Glavni autori: Byrne, Dana D, Tate, Janet P, Forde, Kimberly A, Lim, Joseph K, Goetz, Matthew Bidwell, Rimland, David, Rodriguez-Barradas, Maria C, Butt, Adeel A, Gibert, Cynthia L, Brown, Sheldon T, Bedimo, Roger, Freiberg, Matthew S, Justice, Amy C, Kostman, Jay R, Roy, Jason A, Lo Re, Vincent
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Articles and Commentaries
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850026/
https://ncbi.nlm.nih.gov/pubmed/29020184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix564
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items